-
1
-
-
0034519576
-
Amprenavir. A review of its clinical potential in patients with HIV infection
-
Noble S, Goa KL. Amprenavir. A review of its clinical potential in patients with HIV infection. Drugs. 2000;60:1383-1410.
-
(2000)
Drugs
, vol.60
, pp. 1383-1410
-
-
Noble, S.1
Goa, K.L.2
-
2
-
-
0034685037
-
Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society - USA panel
-
Carpenter CCJ, Cooper DA, Fischl MA, et al. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society - USA panel. JAMA. 2000;283:381-390.
-
(2000)
JAMA
, vol.283
, pp. 381-390
-
-
Carpenter, C.C.J.1
Cooper, D.A.2
Fischl, M.A.3
-
3
-
-
0032562338
-
Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents
-
MMWR
-
MMWR. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Morbid Mortal Wkly Rep. 1998;47(Suppl RR-5):43-83.
-
(1998)
Morbid Mortal Wkly Rep
, vol.47
, Issue.SUPPL. RR-5
, pp. 43-83
-
-
-
4
-
-
0030908131
-
Hepatic and intestinal metabolism of indinavir, an HIV protease inhibitor, in rat and human microsomes. Major role of CYP3A
-
Chiba M, Hensleigh M, Lin JH. Hepatic and intestinal metabolism of indinavir, an HIV protease inhibitor, in rat and human microsomes. Major role of CYP3A. Biochem Pharmacol. 1997;53:1187-1195.
-
(1997)
Biochem Pharmacol
, vol.53
, pp. 1187-1195
-
-
Chiba, M.1
Hensleigh, M.2
Lin, J.H.3
-
5
-
-
0031024382
-
Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: Potential contribution to high first-pass metabolism
-
Fitzsimmons ME, Collins JM. Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism. Drug Metab Dispos. 1997;25:256-266.
-
(1997)
Drug Metab Dispos
, vol.25
, pp. 256-266
-
-
Fitzsimmons, M.E.1
Collins, J.M.2
-
6
-
-
0031790709
-
Metabolism of the human immunodeficiency virus protease inhibitors indinavir and ritonavir by human intestinal microsomes and expressed cytochrome P4503A4/3A5: Mechanism-based inactivation of cytochrome P4503A by ritonavir
-
Koudriakova T, Iatsimirskaia E, Utkin I, et al. Metabolism of the human immunodeficiency virus protease inhibitors indinavir and ritonavir by human intestinal microsomes and expressed cytochrome P4503A4/3A5: mechanism-based inactivation of cytochrome P4503A by ritonavir. Drug Metab Dispos. 1998;26:552-561.
-
(1998)
Drug Metab Dispos
, vol.26
, pp. 552-561
-
-
Koudriakova, T.1
Iatsimirskaia, E.2
Utkin, I.3
-
7
-
-
0033941373
-
Clinical uses of non-nucleoside reverse transcriptase inhibitors
-
Harris M, Montaner JS. Clinical uses of non-nucleoside reverse transcriptase inhibitors. Rev Med Virol. 2000;10:217-229.
-
(2000)
Rev Med Virol
, vol.10
, pp. 217-229
-
-
Harris, M.1
Montaner, J.S.2
-
8
-
-
0032987962
-
Drug interactions of HIV protease inhibitors
-
Malaty LI, Kuper JJ. Drug interactions of HIV protease inhibitors. Drug Saf. 1999;20:147-169.
-
(1999)
Drug Saf
, vol.20
, pp. 147-169
-
-
Malaty, L.I.1
Kuper, J.J.2
-
9
-
-
0032847425
-
Oral absorption of the HIV protease inhibitors: A current update
-
Williams GC, Sinko PJ. Oral absorption of the HIV protease inhibitors: a current update. Adv Drug Deliv Rev. 1999;39:211-238.
-
(1999)
Adv Drug Deliv Rev
, vol.39
, pp. 211-238
-
-
Williams, G.C.1
Sinko, P.J.2
-
10
-
-
0032518290
-
The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors
-
Kim RB, Fromm MF, Wandel C, et al. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest. 1998;101:289-294.
-
(1998)
J Clin Invest
, vol.101
, pp. 289-294
-
-
Kim, R.B.1
Fromm, M.F.2
Wandel, C.3
-
11
-
-
0032894127
-
Human immunodeficiency virus protease inhibitors
-
Rana KZ, Dudley MN. Human immunodeficiency virus protease inhibitors. Pharmacotherapy. 1999;19:35-59.
-
(1999)
Pharmacotherapy
, vol.19
, pp. 35-59
-
-
Rana, K.Z.1
Dudley, M.N.2
-
12
-
-
0036001233
-
Critical issues in therapeutic drug monitoring of antiretroviral drugs
-
Heeswjijk RPG. Critical issues in therapeutic drug monitoring of antiretroviral drugs. Ther Drug Monit. 2002;24:323-331.
-
(2002)
Ther Drug Monit
, vol.24
, pp. 323-331
-
-
Heeswjijk, R.P.G.1
-
13
-
-
0034183765
-
Therapeutic drug monitoring of antiretroviral agents
-
Bean P, Patnaik M, Graziano FM, at al. Therapeutic drug monitoring of antiretroviral agents. Am Clin Lab. 2000;19:20-22.
-
(2000)
Am Clin Lab
, vol.19
, pp. 20-22
-
-
Bean, P.1
Patnaik, M.2
Graziano, F.M.3
-
14
-
-
0036376785
-
Position paper on therapeutic drug monitoring of antiretroviral agents
-
Acosta EP, Gerber JG. Position paper on therapeutic drug monitoring of antiretroviral agents. AIDS Res Hum Retroviruses. 2002;18:825-834.
-
(2002)
AIDS Res Hum Retroviruses
, vol.18
, pp. 825-834
-
-
Acosta, E.P.1
Gerber, J.G.2
-
15
-
-
0037653543
-
Update on HIV pharmacology and therapeutic drug monitoring
-
Flexner CW. Update on HIV pharmacology and therapeutic drug monitoring. Top HIV Med. 2001;9.
-
(2001)
Top HIV Med
, pp. 9
-
-
Flexner, C.W.1
-
16
-
-
0036114874
-
Therapeutic drug monitoring in HIV infection: Current status and future directions
-
Back D, Gatti G, Fletcher C, et al. Therapeutic drug monitoring in HIV infection: current status and future directions. AIDS. 2002;16(Suppl 1):S5-S37.
-
(2002)
AIDS
, vol.16
, Issue.1 SUPPL.
-
-
Back, D.1
Gatti, G.2
Fletcher, C.3
-
17
-
-
0037419657
-
Simultaneous determination of nine antiretroviral compounds in human plasma using liquid chromatography
-
Turner ML, Reed-Walker K, King JR, et al. Simultaneous determination of nine antiretroviral compounds in human plasma using liquid chromatography. J Chromatogr B Anal Technol Biomed Life Sci. 2003;784:331-341.
-
(2003)
J Chromatogr B Anal Technol Biomed Life Sci
, vol.784
, pp. 331-341
-
-
Turner, M.L.1
Reed-Walker, K.2
King, J.R.3
-
18
-
-
0037437590
-
Simultaneous quantitative determination of the HIV protease inhibitors indinavir, amprenavir, ritonavir, lopinavir, saquinavir, nelfinavir and the nelfinavir active metabolite M8 in plasma by liquid chromatography
-
Justesen US, Pedersen C, Klitgaard NA, et al. Simultaneous quantitative determination of the HIV protease inhibitors indinavir, amprenavir, ritonavir, lopinavir, saquinavir, nelfinavir and the nelfinavir active metabolite M8 in plasma by liquid chromatography. J Chromatogr B Anal Technol Biomed Life Sci. 2003;783:491-500.
-
(2003)
J Chromatogr B Anal Technol Biomed Life Sci
, vol.783
, pp. 491-500
-
-
Justesen, U.S.1
Pedersen, C.2
Klitgaard, N.A.3
-
19
-
-
0036333638
-
Simultaneous quantitative assay of six HIV protease inhibitors, one metabolite, and two non-nucleoside reverse transcriptase inhibitors in human plasma by isocratic reversed-phase liquid chromatography
-
Tribut O, Arvieux C, Michelet C, et al. Simultaneous quantitative assay of six HIV protease inhibitors, one metabolite, and two non-nucleoside reverse transcriptase inhibitors in human plasma by isocratic reversed-phase liquid chromatography. Ther Drug Monit. 2002;24:554-562.
-
(2002)
Ther Drug Monit
, vol.24
, pp. 554-562
-
-
Tribut, O.1
Arvieux, C.2
Michelet, C.3
-
20
-
-
0036001242
-
High-performance liquid chromatographic method for the simultaneous determination of the six HIV-protease inhibitors and two non-nucleoside reverse transcriptase inhibitors in human plasma
-
Titier K, Lagrange F, Pehourcq F, et al. High-performance liquid chromatographic method for the simultaneous determination of the six HIV-protease inhibitors and two non-nucleoside reverse transcriptase inhibitors in human plasma. Ther Drug Monit. 2002;24:417-424.
-
(2002)
Ther Drug Monit
, vol.24
, pp. 417-424
-
-
Titier, K.1
Lagrange, F.2
Pehourcq, F.3
-
21
-
-
0037296349
-
Rapid quantification of HIV protease inhibitors in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry
-
Crommentuyn KML, Rosing H, Nan-Offeringa LGAH, et al. Rapid quantification of HIV protease inhibitors in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. J Mass Spectrom. 2003;38:157-166.
-
(2003)
J Mass Spectrom
, vol.38
, pp. 157-166
-
-
Crommentuyn, K.M.L.1
Rosing, H.2
Nan-Offeringa, L.G.A.H.3
-
23
-
-
0037201562
-
Simultaneous determination of five HIV protease inhibitors nelfinavir, indinavir, ritonavir, saquinavir and amprenavir in human plasma by LC/MS/MS
-
Chi J, Jayewardene AL, Stone JA, et al. Simultaneous determination of five HIV protease inhibitors nelfinavir, indinavir, ritonavir, saquinavir and amprenavir in human plasma by LC/MS/MS. J Pharm Biomed Anal. 2002;30:675-684.
-
(2002)
J Pharm Biomed Anal
, vol.30
, pp. 675-684
-
-
Chi, J.1
Jayewardene, A.L.2
Stone, J.A.3
-
24
-
-
4744337889
-
Pharmacokinetic interactions between cyclosporine and protease inhibitors in HIV+ subjects
-
Frassetto L, Thien T, Aggarwal AM, et al. Pharmacokinetic interactions between cyclosporine and protease inhibitors in HIV+ subjects. Eur J Drug Metab Pharmacokinet. 2003;18:114-120.
-
(2003)
Eur J Drug Metab Pharmacokinet
, vol.18
, pp. 114-120
-
-
Frassetto, L.1
Thien, T.2
Aggarwal, A.M.3
-
25
-
-
0042554198
-
Determination of drugs and their metabolites in biological samples by fully automated HPLC with on-line solid-liquid extraction and pre-column switching
-
Frei RW, Zech K, eds. Amsterdam: Elsevier
-
Huber R, Zech K. Determination of drugs and their metabolites in biological samples by fully automated HPLC with on-line solid-liquid extraction and pre-column switching. In: Frei RW, Zech K, eds. Selective Sample Handling and Detection in High-Performance Liquid Chromatography, Vol 39A. Amsterdam: Elsevier, 1988:81-144.
-
(1988)
Selective Sample Handling and Detection in High-Performance Liquid Chromatography
, vol.39 A
, pp. 81-144
-
-
Huber, R.1
Zech, K.2
-
26
-
-
4744371161
-
-
January
-
THE NATAP REPORTS web site. January 1998. Available at: http:// www.natap.org/1998/98reports/natap_reports3.5. Accessed January 28, 2004.
-
(1998)
THE NATAP REPORTS Web Site
-
-
-
27
-
-
4744371705
-
Clinical Considerations in Therapeutic Drug Monitoring
-
February
-
Luber AD, Hardy WD. Clinical Considerations in Therapeutic Drug Monitoring. [THE BODY, HIVNEWSLINE web site]. February 2001. Available at: http://www.thebody.com/hivnews/newsline/feb2001/optimal2. Accessed January 28, 2004.
-
(2001)
THE BODY, HIVNEWSLINE Web Site
-
-
Luber, A.D.1
Hardy, W.D.2
-
28
-
-
9144233476
-
Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: A 48-week randomized clinical trial
-
Eron JJ, Feinberg J, Kessler HA. Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trial. J Infect Dis. 2004;189:265-272.
-
(2004)
J Infect Dis
, vol.189
, pp. 265-272
-
-
Eron, J.J.1
Feinberg, J.2
Kessler, H.A.3
-
29
-
-
0032870854
-
Drug monitoring of antiretroviral therapy for HIV-1 infection: Method validation and results of a pilot study
-
Moyer TP, Temesgen Z, Enger R, et al. Drug monitoring of antiretroviral therapy for HIV-1 infection: method validation and results of a pilot study. Clin Chem. 1999;45:1465-1476.
-
(1999)
Clin Chem
, vol.45
, pp. 1465-1476
-
-
Moyer, T.P.1
Temesgen, Z.2
Enger, R.3
-
30
-
-
0032847425
-
Oral absorption of the HIV protease inhibitors: A current update
-
Williams GC, Sinko PJ. Oral absorption of the HIV protease inhibitors: a current update. Adv Drug Deliv Rev. 1999;39:211-238.
-
(1999)
Adv Drug Deliv Rev
, vol.39
, pp. 211-238
-
-
Williams, G.C.1
Sinko, P.J.2
-
31
-
-
12444324502
-
Therapeutic drug monitoring: An aid to optimising response to antiretroviral drugs?
-
Aarnoutse RE, Schapiro JM, Boucher CA, et al. Therapeutic drug monitoring: an aid to optimising response to antiretroviral drugs? Drugs. 2003; 63:741-753.
-
(2003)
Drugs
, vol.63
, pp. 741-753
-
-
Aarnoutse, R.E.1
Schapiro, J.M.2
Boucher, C.A.3
-
32
-
-
0026336726
-
Analytical methods validation - Bioavailability, bioequivalence and pharmacokinetic studies - Conference Report
-
Shah VP, Midha KK, Dighe S, et al. Analytical methods validation - bioavailability, bioequivalence and pharmacokinetic studies - Conference Report. Eur J Drug Metab Pharmacokinet. 1991;16:249-255.
-
(1991)
Eur J Drug Metab Pharmacokinet
, vol.16
, pp. 249-255
-
-
Shah, V.P.1
Midha, K.K.2
Dighe, S.3
-
33
-
-
0037099577
-
Determination of lopinavir and nevirapine by high-performance liquid chromatography after solid-phase extraction: Application for the assessment of their transplacental passage at delivery
-
Marzolini C, Beguin A, Telenti A, et al. Determination of lopinavir and nevirapine by high-performance liquid chromatography after solid-phase extraction: application for the assessment of their transplacental passage at delivery. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;774: 127-140.
-
(2002)
J Chromatogr B Analyt Technol Biomed Life Sci
, vol.774
, pp. 127-140
-
-
Marzolini, C.1
Beguin, A.2
Telenti, A.3
-
34
-
-
0037466749
-
Sensitive and specific determination of eight antiretroviral agents in plasma by high-performance liquid chromatography-mass spectrometry
-
Rentsch KM. Sensitive and specific determination of eight antiretroviral agents in plasma by high-performance liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;788:339-350.
-
(2003)
J Chromatogr B Analyt Technol Biomed Life Sci
, vol.788
, pp. 339-350
-
-
Rentsch, K.M.1
-
35
-
-
0034306732
-
Automated, fast and sensitive quantification of drugs in blood by liquid chromatography-mass spectrometry with on-line extraction: Immunosuppressants
-
Christians U, Jacobsen W, Serkova N, et al. Automated, fast and sensitive quantification of drugs in blood by liquid chromatography-mass spectrometry with on-line extraction: immunosuppressants. J Chromatogr B Analyt Technol Biomed Life Sci. 2000;748:41-53.
-
(2000)
J Chromatogr B Analyt Technol Biomed Life Sci
, vol.748
, pp. 41-53
-
-
Christians, U.1
Jacobsen, W.2
Serkova, N.3
|